These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11906745)

  • 41. The Caenorhabditis elegans muscle-affecting gene unc-87 encodes a novel thin filament-associated protein.
    Goetinck S; Waterston RH
    J Cell Biol; 1994 Oct; 127(1):79-93. PubMed ID: 7929573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Programmed cell death. A rich harvest.
    Hengartner MO
    Curr Biol; 1994 Oct; 4(10):950-2. PubMed ID: 7850439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stn-1 syntrophin gene of C.elegans is functionally related to dystrophin and dystrobrevin.
    Grisoni K; Gieseler K; Mariol MC; Martin E; Carre-Pierrat M; Moulder G; Barstead R; Ségalat L
    J Mol Biol; 2003 Oct; 332(5):1037-46. PubMed ID: 14499607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caenorhabditis elegans: how good a model for veterinary parasites?
    Geary TG; Thompson DP
    Vet Parasitol; 2001 Nov; 101(3-4):371-86. PubMed ID: 11707307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caenorhabditis elegans HUS-1 is a DNA damage checkpoint protein required for genome stability and EGL-1-mediated apoptosis.
    Hofmann ER; Milstein S; Boulton SJ; Ye M; Hofmann JJ; Stergiou L; Gartner A; Vidal M; Hengartner MO
    Curr Biol; 2002 Nov; 12(22):1908-18. PubMed ID: 12445383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cadmium-induced germline apoptosis in Caenorhabditis elegans: the roles of HUS1, p53, and MAPK signaling pathways.
    Wang S; Tang M; Pei B; Xiao X; Wang J; Hang H; Wu L
    Toxicol Sci; 2008 Apr; 102(2):345-51. PubMed ID: 17728284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic evidence for a dystrophin-glycoprotein complex (DGC) in Caenorhabditis elegans.
    Grisoni K; Martin E; Gieseler K; Mariol MC; Ségalat L
    Gene; 2002 Jul; 294(1-2):77-86. PubMed ID: 12234669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Confessions of a professional Worm Wrangler and Mouse Herder: the benefits of a hybrid career.
    Wheeler JM
    Lab Anim (NY); 2020 Feb; 49(2):33-35. PubMed ID: 31959943
    [No Abstract]   [Full Text] [Related]  

  • 50. Rose Essential Oil Delayed Alzheimer's Disease-Like Symptoms by SKN-1 Pathway in C. elegans.
    Zhu S; Li H; Dong J; Yang W; Liu T; Wang Y; Wang X; Wang M; Zhi D
    J Agric Food Chem; 2017 Oct; 65(40):8855-8865. PubMed ID: 28915354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods for detection and analysis of apoptosis signaling in the C. elegans germline.
    Lant B; Derry WB
    Methods; 2013 Jun; 61(2):174-82. PubMed ID: 23643851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans.
    Wilkins C; Dishongh R; Moore SC; Whitt MA; Chow M; Machaca K
    Nature; 2005 Aug; 436(7053):1044-7. PubMed ID: 16107852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The presenilin mystery. The research winner-by-a knockout?].
    Checler F
    C R Acad Sci III; 1999 Dec; 322(12):1033-8. PubMed ID: 10656144
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic clues to Alzheimer's disease.
    Dewji NN; Singer SJ
    Science; 1996 Jan; 271(5246):159-60. PubMed ID: 8539612
    [No Abstract]   [Full Text] [Related]  

  • 55. Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.
    Giacomotto J; Ségalat L; Carre-Pierrat M; Gieseler K
    Methods; 2012 Jan; 56(1):103-13. PubMed ID: 22041718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homologous gene targeting in Caenorhabditis elegans by biolistic transformation.
    Berezikov E; Bargmann CI; Plasterk RH
    Nucleic Acids Res; 2004 Feb; 32(4):e40. PubMed ID: 14982959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From bugs to bedside: functional annotation of human genetic variation for neurological disorders using invertebrate models.
    Mew M; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2022 Oct; 31(R1):R37-R46. PubMed ID: 35994032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene.
    Levitan D; Greenwald I
    Nature; 1995 Sep; 377(6547):351-4. PubMed ID: 7566091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.